SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-189498
Filing Date
2018-06-11
Accepted
2018-06-11 16:40:36
Documents
5
Effectiveness Date
2018-06-11

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d603943ds8.htm S-8 42396
2 EX-5.1 d603943dex51.htm EX-5.1 5399
3 EX-23.1 d603943dex231.htm EX-23.1 1745
4 EX-99.1 d603943dex991.htm EX-99.1 138029
5 GRAPHIC g603943g0608070508981.jpg GRAPHIC 2524
  Complete submission text file 0001193125-18-189498.txt   192319
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-225554 | Film No.: 18892473
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences